Descargar PDF

Otros usuarios también vieron estos artículos

Acute kidney injury with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: Foe or friend? Dimitrios Patoulias, Christodoulos Papadopoulos, Fotios Siskos, Michael Doumas
10.1016/j.nefro.2021.05.012
Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen, Reem Sayad, Alyaa Khaled Abdelmonem, Katia Latifa, Lina Musallam, Moustafa Abouelkheir, Sherif Mira, Ahmed Awad, Ahmed Afsa, Waleed Nassar, Gehad El Ashal, Mohamed Elmasry, Eshak I. Bahbah
10.1016/j.nefro.2025.501345
FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction Ture Lange Nielsen, Louis Lind Plesner, Peder Emil Warming, Ole Hartvig Mortensen, Kasper Karmark Iversen, James Goya Heaf
10.1016/j.nefro.2018.10.007